Benjamin Ruf

2.1k total citations · 1 hit paper
29 papers, 869 citations indexed

About

Benjamin Ruf is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Benjamin Ruf has authored 29 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 14 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Benjamin Ruf's work include Immune Cell Function and Interaction (12 papers), Cancer Immunotherapy and Biomarkers (7 papers) and T-cell and B-cell Immunology (4 papers). Benjamin Ruf is often cited by papers focused on Immune Cell Function and Interaction (12 papers), Cancer Immunotherapy and Biomarkers (7 papers) and T-cell and B-cell Immunology (4 papers). Benjamin Ruf collaborates with scholars based in United States, Germany and United Kingdom. Benjamin Ruf's co-authors include Tim F. Greten, Bernd Heinrich, Firouzeh Korangy, Xin Wei Wang, Chi Ma, Simon Wabitsch, Laurence P. Diggs, John C. McVey, Eytan Ruppin and Mark Yarchoan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature reviews. Cancer and The Journal of Immunology.

In The Last Decade

Benjamin Ruf

28 papers receiving 868 citations

Hit Papers

Biomarkers for immunotherapy of hepatocellular carcinoma 2023 2026 2024 2025 2023 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin Ruf United States 14 343 298 280 192 146 29 869
Adeel ur Rehman China 10 324 0.9× 453 1.5× 273 1.0× 193 1.0× 73 0.5× 27 917
Miaojun Han United States 9 182 0.5× 190 0.6× 225 0.8× 305 1.6× 188 1.3× 10 738
Ruizhao Qi China 11 325 0.9× 220 0.7× 222 0.8× 114 0.6× 192 1.3× 20 706
Sandra Ortiz‐Cuaran France 16 527 1.5× 151 0.5× 486 1.7× 125 0.7× 93 0.6× 35 1.0k
Kit Man Wong United States 13 233 0.7× 163 0.5× 368 1.3× 90 0.5× 31 0.2× 32 793
Shanshan Liu China 14 199 0.6× 146 0.5× 324 1.2× 64 0.3× 64 0.4× 43 764
Idrees Mian United States 11 210 0.6× 79 0.3× 455 1.6× 202 1.1× 244 1.7× 15 1.1k
Fubiao Kang China 15 323 0.9× 370 1.2× 234 0.8× 110 0.6× 73 0.5× 26 782
Yonggang Lv China 16 208 0.6× 174 0.6× 224 0.8× 151 0.8× 44 0.3× 28 648
Jérôme Mahiou United States 12 120 0.3× 408 1.4× 390 1.4× 84 0.4× 65 0.4× 15 925

Countries citing papers authored by Benjamin Ruf

Since Specialization
Citations

This map shows the geographic impact of Benjamin Ruf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Ruf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Ruf more than expected).

Fields of papers citing papers by Benjamin Ruf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Ruf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Ruf. The network helps show where Benjamin Ruf may publish in the future.

Co-authorship network of co-authors of Benjamin Ruf

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Ruf. A scholar is included among the top collaborators of Benjamin Ruf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Ruf. Benjamin Ruf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ruf, Benjamin, Patrick Huang, Chi Ma, et al.. (2025). Activating Mucosal-Associated Invariant T (MAIT) cells for next generation immunotherapy of liver cancer. Zeitschrift für Gastroenterologie. 63. 1 indexed citations
2.
Wistuba‐Hamprecht, Kilian, et al.. (2024). Innate-like T cells in liver disease. Trends in Immunology. 45(7). 535–548. 12 indexed citations
3.
Green, Benjamin L., Yuta Myojin, Chi Ma, et al.. (2023). Immunosuppressive CD29 + Treg accumulation in the liver in mice on checkpoint inhibitor therapy. Gut. 73(3). 509–520. 7 indexed citations
4.
Myojin, Yuta, Justin McCallen, Chi Ma, et al.. (2023). Adenosine A2a receptor inhibition increases the anti-tumor efficacy of anti-PD1 treatment in murine hepatobiliary cancers. JHEP Reports. 6(1). 100959–100959. 12 indexed citations
5.
Monge, Cecilia, Changqing Xie, Yuta Myojin, et al.. (2023). Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer. Journal for ImmunoTherapy of Cancer. 11(2). e005640–e005640. 46 indexed citations
6.
Wang, Xin, Benjamin Ruf, Michael E. Kelly, et al.. (2023). Anti-Cancer Activity of Verteporfin in Cholangiocarcinoma. Cancers. 15(9). 2454–2454. 8 indexed citations
7.
Bauer, Kylynda C., Benjamin Ruf, Yuta Myojin, et al.. (2023). 988 Vagal-CD8+ T cell neuroimmune axis modulates liver cancer. SHILAP Revista de lepidopterología. A1095–A1095.
8.
McVey, John C., Benjamin L. Green, Benjamin Ruf, et al.. (2022). NAFLD indirectly impairs antigen-specific CD8+ T cell immunity against liver cancer in mice. iScience. 25(2). 103847–103847. 18 indexed citations
9.
Wabitsch, Simon, Justin McCallen, Olena Kamenyeva, et al.. (2022). Metformin treatment rescues CD8+ T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD. Journal of Hepatology. 77(3). 748–760. 98 indexed citations
10.
Heinrich, Bernd, Benjamin Ruf, Varun Subramanyam, et al.. (2022). Checkpoint Inhibitors Modulate Plasticity of Innate Lymphoid Cells in Peripheral Blood of Patients With Hepatocellular Carcinoma. Frontiers in Immunology. 13. 849958–849958. 8 indexed citations
11.
Ruf, Benjamin, Cristiana Roggia, Christopher Schroeder, et al.. (2022). Chromoendoscopy in Combination with Random Biopsies for Patients with Pathogenic CDH1 Mutations Undergoing Endoscopic Surveillance. Journal of Gastrointestinal Cancer. 54(2). 520–527. 3 indexed citations
12.
Ruf, Benjamin, Simon Wabitsch, Chi Ma, et al.. (2021). Activating Mucosal-Associated Invariant T Cells Induces a Broad Antitumor Response. Cancer Immunology Research. 9(9). 1024–1034. 39 indexed citations
13.
Wabitsch, Simon, John C. McVey, Chi Ma, et al.. (2020). Hydroxychloroquine can impair tumor response to anti-PD1 in subcutaneous mouse models. iScience. 24(1). 101990–101990. 15 indexed citations
14.
Heinrich, Bernd, Zachary J. Brown, Laurence P. Diggs, et al.. (2020). Steatohepatitis Impairs T-cell–Directed Immunotherapies Against Liver Tumors in Mice. Gastroenterology. 160(1). 331–345.e6. 55 indexed citations
15.
Ruf, Benjamin, Bernd Heinrich, & Tim F. Greten. (2020). Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells. Cellular and Molecular Immunology. 18(1). 112–127. 213 indexed citations
16.
Yurlova, Larisa, A. Scholz, Benjamin Ruf, et al.. (2016). A New Nanobody-Based Biosensor to Study Endogenous PARP1 In Vitro and in Live Human Cells. PLoS ONE. 11(3). e0151041–e0151041. 33 indexed citations
17.
Ruf, Benjamin & Ulrich M. Lauer. (2015). Assessment of current virotherapeutic application schemes: “hit hard and early” versus “killing softly”?. Molecular Therapy — Oncolytics. 2. 15018–15018. 12 indexed citations
18.
Ruf, Benjamin, Susanne Berchtold, Sascha Venturelli, et al.. (2015). Combination of the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus as a new option for epi-virotherapeutic treatment of hepatocellular carcinoma. Molecular Therapy — Oncolytics. 2. 15019–15019. 26 indexed citations
19.
Grünewald, Thomas, et al.. (1997). Selective Expansion of γδ T Cells among Liver-Derived Lymphocytes of AIDS Patients with DisseminatedMycobacterium aviumComplex Infection. Clinical Immunology and Immunopathology. 85(2). 151–157. 4 indexed citations
20.
Tintelnot, Kathrin, et al.. (1996). Port‐a‐cath‐related Fusarium oxysporum infection in an HIV‐infected patient: treatment with liposomal amphotericin B. Mycoses. 39(3-4). 115–119. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026